Eltrombopag, a second-generation thrombopoietin receptor agonist, for chronic lymphocytic leukemia-associated ITP.

Suppr

超能文献

作者信息

Koehrer S, Keating M J, Wierda W G

出版信息

Leukemia. 2010 May;24(5):1096-8. doi: 10.1038/leu.2010.45. Epub 2010 Mar 25.

DOI:10.1038/leu.2010.45

PMID:20339441

Abstract

摘要

相似文献

Eltrombopag, a second-generation thrombopoietin receptor agonist, for chronic lymphocytic leukemia-associated ITP.

Leukemia. 2010 May;24(5):1096-8. doi: 10.1038/leu.2010.45. Epub 2010 Mar 25.

Eltrombopag--an oral thrombopoietin agonist.艾曲波帕——一种口服促血小板生成素激动剂。

Eur Rev Med Pharmacol Sci. 2012 Jun;16(6):743-6.

Eltrombopag for resistant immune thrombocytopenia secondary to chronic lymphocytic leukaemia.艾曲泊帕用于慢性淋巴细胞白血病继发的难治性免疫性血小板减少症。

Intern Med J. 2014 Jul;44(7):697-9. doi: 10.1111/imj.12468.

Eltrombopag for chronic immune thrombocytopenia.艾曲泊帕用于慢性免疫性血小板减少症。

Lancet. 2016 Jan 23;387(10016):336. doi: 10.1016/S0140-6736(16)00107-0.

Eltrombopag for chronic immune thrombocytopenia - Authors' reply.艾曲泊帕用于慢性免疫性血小板减少症——作者回复

Lancet. 2016 Jan 23;387(10016):336-337. doi: 10.1016/S0140-6736(16)00009-X.

Thrombopoietin Receptor Agonists: Eltrombopag and Romiplostim for the Treatment of Chronic Immune Thrombocytopenia Purpura.血小板生成素受体激动剂：艾曲泊帕和罗米司亭用于治疗慢性免疫性血小板减少性紫癜

Clin J Oncol Nurs. 2019 Apr 1;23(2):212-216. doi: 10.1188/19.CJON.212-216.

Idiopathic thrombocytopenic purpura resistant to eltrombopag, but cured with romiplostim.对艾曲泊帕耐药但用罗米司亭治愈的特发性血小板减少性紫癜

Blood Transfus. 2014 Jan;12 Suppl 1(Suppl 1):s149-50. doi: 10.2450/2013.0289-12. Epub 2013 Apr 17.

Sustaining platelet counts in chronic ITP.维持慢性免疫性血小板减少症患者的血小板计数

Lancet. 2011 Jan 29;377(9763):358-60. doi: 10.1016/S0140-6736(10)61090-2. Epub 2010 Aug 23.

[Development of myelofibrosis during eltrombopag treatment in a patient with immune thrombocytopenia].[一名免疫性血小板减少症患者在接受艾曲泊帕治疗期间发生骨髓纤维化]

Rinsho Ketsueki. 2016 May;57(5):638-41. doi: 10.11406/rinketsu.57.638.

Eltrombopag in thrombocytopenia.艾曲泊帕用于血小板减少症。

N Engl J Med. 2008 Mar 6;358(10):1072; author reply 1072-3.

引用本文的文献

Eltrombopag improves refractory thrombocytopenia in patients with Sjögren's syndrome.依鲁替尼改善干燥综合征患者的难治性血小板减少症。

Sci Prog. 2022 Apr-Jun;105(2):368504221102786. doi: 10.1177/00368504221102786.

Autoimmune Cytopenias in Chronic Lymphocytic Leukemia: Focus on Molecular Aspects.慢性淋巴细胞白血病中的自身免疫性血细胞减少症：聚焦分子层面

Front Oncol. 2020 Jan 10;9:1435. doi: 10.3389/fonc.2019.01435. eCollection 2019.

A phase II trial of eltrombopag for patients with chronic lymphocytic leukaemia (CLL) and thrombocytopenia.艾曲泊帕用于慢性淋巴细胞白血病（CLL）和血小板减少症患者的II期试验。

Br J Haematol. 2019 May;185(3):606-608. doi: 10.1111/bjh.15581. Epub 2018 Nov 8.

Repeated successful use of eltrombopag in chronic primary immune thrombocytopenia: description of an intriguing case.艾曲泊帕在慢性原发性免疫性血小板减少症中的反复成功应用：一则有趣病例的描述。

Clin Case Rep. 2017 Jul 13;5(8):1385-1388. doi: 10.1002/ccr3.920. eCollection 2017 Aug.

Successful Long-Term Use of Eltrombopag in a Patient with Refractory Severe Thrombocytopenia Associated with Chronic Lymphocytic Leukemia That Allowed Oral Anticoagulant Treatment for Severe Cardiomyopathy.艾曲泊帕在一名伴有慢性淋巴细胞白血病的难治性严重血小板减少症患者中的长期成功应用，该患者因严重心肌病得以接受口服抗凝治疗。

Case Rep Hematol. 2017;2017:9538920. doi: 10.1155/2017/9538920. Epub 2017 Apr 2.

A Concise Review of Autoimmune Cytopenias in Chronic Lymphocytic Leukemia.慢性淋巴细胞白血病中自身免疫性血细胞减少症的简要综述

Curr Hematol Malig Rep. 2017 Feb;12(1):29-38. doi: 10.1007/s11899-017-0366-1.

Heterogeneity of leukemia-initiating capacity of chronic myelogenous leukemia stem cells.慢性粒细胞白血病干细胞启动白血病能力的异质性。

J Clin Invest. 2016 Mar 1;126(3):975-91. doi: 10.1172/JCI79196. Epub 2016 Feb 15.

Autoimmune cytopenias in chronic lymphocytic leukemia, facts and myths.慢性淋巴细胞白血病中的自身免疫性血细胞减少症：事实与误解

Mediterr J Hematol Infect Dis. 2013 Nov 4;5(1):e2013068. doi: 10.4084/MJHID.2013.068.

Autoimmune cytopenias in chronic lymphocytic leukemia.慢性淋巴细胞白血病中的自身免疫性血细胞减少症。

Clin Dev Immunol. 2013;2013:730131. doi: 10.1155/2013/730131. Epub 2013 Apr 16.

The use of monoclonal antibodies in the treatment of autoimmune complications of chronic lymphocytic leukemia.单克隆抗体在治疗慢性淋巴细胞白血病自身免疫并发症中的应用。

Mediterr J Hematol Infect Dis. 2013 Apr 10;5(1):e2013027. doi: 10.4084/MJHID.2013.027. Print 2013.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验